| Bioequivalence of Two Tacrolimus 0.1% Topical Ointment Formulations in Patients With Atopic Dermatitis (NCT00833079) | Sun Pharmaceutical Industries, Inc. | 2008-10-01 |
| Safety Study of Tezepelumab (AMG 157) in Healthy Adults and Adults With Atopic Dermatitis (NCT00757042) | Amgen | 2008-09-18 |
| Immune Response to Yellow Fever Vaccination in Adults With Atopic Dermatitis (NCT00723489) | National Institute of Allergy and Infectious Diseases (NIAID) | 2008-08-01 |
| Dose-Finding Study of M516102 in the Treatment of Pruritus Associated With Atopic Dermatitis (NCT00980629) | Maruho Co., Ltd. | 2008-08-01 |
| A Phase I Study to Assess the Safety and Tolerability of Topical CRx-197 Formulations in Healthy Volunteers (NCT00721331) | Zalicus | 2008-07-01 |
| A Phase 2 Study of PH-10 for the Treatment of Atopic Dermatitis (NCT00690807) | Provectus Pharmaceuticals | 2008-06-01 |
| A Randomized, Double-Blind Study to Evaluate the Safety and Efficacy of 2 Doses of S-777469 in Patients With Atopic Dermatitis (NCT00703573) | Shionogi | 2008-05-01 |
| Potential Research Study Participant Registry (NCT00710489) | University of California, Davis | 2008-05-01 |
| Measuring Adherence to Topical Therapy in Children With Atopic Dermatitis and the Impact of a Return Visit (NCT00654355) | Wake Forest University | 2008-04-01 |
| Efficacy Study of Montelukast in Atopic Dermatitis Induced by Food Allergens (NCT00557284) | 1st Allergy & Clinical Research Center | 2008-03-01 |
| A Randomized, Double-blinded Placebo-controlled Study to Investigate Antimicrobial Efficacy and Safety Following Topical Application of DPK-060 (NCT01522391) | DermaGen AB | 2008-03-01 |
| Studies of Skin Microbes in Healthy People and in People With Skin Conditions (NCT00605878) | National Human Genome Research Institute (NHGRI) | 2008-01-22 |
| Study of 0416 Ointment in the Treatment of Atopic Dermatitis (NCT01053247) | Fougera Pharmaceuticals Inc. | 2008-01-01 |
| Study to Evaluate the Safety and Efficacy of Alefacept (Amevive) in Subjects With Moderate to Severe Atopic Dermatitis (NCT00832585) | Rush University Medical Center | 2008-01-01 |
| Responses to Immunization With Keyhole Limpet Hemocyanin Administered by Scarification and the Intradermal Route (NCT00614731) | National Institute of Allergy and Infectious Diseases (NIAID) | 2007-12-01 |
| Safety and Efficacy Study of ImCOOH Cream in Patients Suffering From Moderate Atopic Dermatitis (NCT00583895) | Valletta Health B.V. | 2007-12-01 |
| Comparison of Atrophogenic Effect of Hydrocortison 1% Cream and Pimecrolimus 1% Cream Assessed by Optical Coherence Tomography (OCT) and 20-MHz Ultrasound of Uninvolved Skin in Patients With Atopic Dermatitis (NCT00610142) | Technische Universität Dresden | 2007-12-01 |
| The Effect of Visual Stimuli on Itch Perception Intensity in Healthy and Atopic Dermatitis Patients (NCT00660127) | Wake Forest University Health Sciences | 2007-10-01 |
| Efficacy of Desonide (Desonatetm) Gel 0.05% in Younger and Older Subjects With Atopic Dermatitis (NCT00690833) | Wake Forest University | 2007-08-01 |
| A Phase Ib/IIa, Double-Blind, Randomized Study to Assess the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of S-777469 in Subjects With Atopic Dermatitis (NCT00697710) | Shionogi | 2007-07-01 |
| Cutivate Lotion HPA Axis Pediatric Study (NCT00546000) | Fougera Pharmaceuticals Inc. | 2007-07-01 |
| Epiceram Versus Elidel for Treatment of Mild to Moderate Atopic Dermatitis (NCT00460083) | Ceragenix Pharmaceuticals | 2007-04-01 |
| An Efficacy and Safety Study of JNJ-26113100 in the Treatment of Adult Atopic Dermatitis (NCT00455429) | Johnson & Johnson Pharmaceutical Research & Development, L.L.C. | 2007-04-01 |
| Prednisolone vs. Ciclosporine in Severe Atopic Eczema (NCT00445081) | Technische Universität Dresden | 2007-03-01 |
| Comprehensive Investigation of Heart Rate Variability as a Measure of the Autonomic Nervous System in Atopic Dermatitis (NCT00691366) | Wake Forest University | 2007-03-01 |
| Polish Mother and Child Cohort Study (REPRO_PL) - Follow up of the Children. (NCT01861548) | Medical University of Lodz | 2007-01-01 |
| A Study of a Probiotic in Atopic Dermatitis (NCT00893230) | Chungbuk National University | 2007-01-01 |
| Epiceram™ Device Versus Mid-Strength Topical Steroid (Fluticasone Propionate 0.05%) for Treatment of Atopic Dermatitis (NCT00616538) | Ceragenix Pharmaceuticals | 2006-12-01 |
| An Open-Label Study Investigating the Effects of Early Skin Barrier Protection on the Development of Atopic Dermatitis (NCT00806221) | Oregon Health and Science University | 2006-11-01 |
| Probiotic Bacteria to Infants With Atopic Dermatitis (NCT01007331) | University of Copenhagen | 2006-11-01 |
| Study of Pimecrolimus Treatment for Atopic Dermatitis of African American Children (NCT00810862) | Children's Hospital of Michigan | 2006-11-01 |
| Adherence to Topical Hydrocortisone 17-butyrate 0.1% (Locoid®) Using Different Vehicles in Adults With Atopic Dermatitis (NCT00693693) | Wake Forest University | 2006-11-01 |
| Safety Study of MVA Smallpox Vaccine in Subjects With a History of Atopic Dermatitis (AD) (NCT00389103) | Sanofi Pasteur, a Sanofi Company | 2006-10-01 |
| LEO19123 Cream in the Treatment of Atopic Dermatitis (NCT00392067) | LEO Pharma | 2006-10-01 |
| Effects of Pimecrolimus on Skin Biopsy Ex-plants From Patients With Atopic Dermatitis (NCT00379678) | National Jewish Health | 2006-09-01 |
| Molecular and Cellular Characterization of Spongiotic Dermatitis (NCT00371163) | University of California, Davis | 2006-09-01 |
| A Phase II Study on Immunogenicity and Safety of MVA-BN® (IMVAMUNE™) Smallpox Vaccine in Subjects With Atopic Dermatitis (NCT00316602) | Bavarian Nordic | 2006-07-01 |
| Identifying Genetic Determinants of Eczema Herpeticum and Other Viral Infections in Individuals With Atopic Dermatitis (NCT00515047) | National Institute of Allergy and Infectious Diseases (NIAID) | 2006-05-01 |
| Efficacy and Safety Trial of ALK-depot SQ Mites in Subjects With Atopic Dermatitis (NCT00310492) | ALK-Abelló A/S | 2006-04-01 |
| Comprehensive Investigation of Opiates, Neuropeptides, Barrier Function, Scratching and Sleep Physiology (NCT00696397) | Wake Forest University | 2006-03-01 |
| Identifying Risk Factors for Eczema Herpeticum in Individuals With Atopic Dermatitis (NCT00438022) | National Institute of Allergy and Infectious Diseases (NIAID) | 2006-03-01 |
| Reconstitution With Pimecrolimus Cream 1% of Steroid-damaged Skin in Adults With Atopic Dermatitis (NCT00367393) | Novartis | 2006-03-01 |
| Topical GW842470X In Adults Patients With Moderate Atopic Dermatitis (NCT00354510) | GlaxoSmithKline | 2006-03-01 |
| Open-Label,Singel Center Study of Alefacept in Patients With Atopic Dermatitis (NCT00376129) | Insel Gruppe AG, University Hospital Bern | 2006-01-01 |
| Immune Response to Varicella Vaccination in Children With Atopic Dermatitis (NCT00406081) | National Institute of Allergy and Infectious Diseases (NIAID) | 2005-12-01 |
| The Impact of Treating Staphylococcus Aureus Infection and Colonization on the Clinical Severity of Atopic Dermatitis (NCT00179959) | Northwestern University | 2005-09-01 |
| Efficacy and Safety of Pimecrolimus Cream 1% in Patients (2 to 11 Years Old) With Mild to Moderate Facial Atopic Dermatitis (NCT00130364) | Novartis | 2005-08-01 |
| Comparison of Cathelicidin Expression in Skin and Saliva in Patients With Atopic Dermatitis and Psoriasis (NCT00407979) | National Institute of Allergy and Infectious Diseases (NIAID) | 2005-07-01 |
| Common Allergens in Skin Tests for Adult Atopic Dermatitis (NCT00173498) | National Taiwan University Hospital | 2005-07-01 |
| 10 Year Registry of Children (Ages 2-17 Years) With Eczema That Have Used Pimecrolimus (NCT00568997) | Bausch Health Americas, Inc. | 2005-06-27 |
| Role of Antimicrobial Peptides in Host Defense Against Vaccinia Virus (NCT00407069) | National Institute of Allergy and Infectious Diseases (NIAID) | 2005-06-01 |
| A Pediatric Longitudinal Evaluation to Assess the Long-Term Safety of Protopic for the Treatment of Atopic Dermatitis (NCT00475605) | LEO Pharma | 2005-05-25 |
| Open Label Study of Long Term Treatment of Pediatric Treatment of Atopic Dermatitis With Pimecrolimus Cream 1% Within a Usual Clinical Setting (NCT00509990) | Novartis Pharmaceuticals | 2005-04-01 |
| Elidel-Study: Elidel in Patients With Atopic Dermatitis (NCT00180141) | Technische Universität Dresden | 2005-04-01 |
| Pimecrolimus and Epidermal Barrier Function (NCT01132079) | University of Kiel | 2005-03-01 |
| Quality of Life Study in Adults With Facial Eczema (NCT00120302) | Novartis | 2005-03-01 |
| Topical NF-kappaB Decoy in the Treatment of Atopic Dermatitis (NCT00125333) | Anesiva, Inc. | 2005-03-01 |
| Short Term Growth in Children With Atopic Dermatitis (NCT00236106) | Children´s Clinic, Randers | 2005-02-01 |
| Prospective, Randomized, Double Blind Comparative Study on the Use of Two Creams in Xerosis Atopic Probands (NCT00509535) | L'Oreal | 2005-01-01 |
| The Effect of a Probiotic Intervention in Healthy Subjects and Patients With Atopic Dermatitis (NCT00550472) | University of Jena | 2004-12-01 |
| Assessment of Pruritus Improvement With Pimecrolimus Treatment on the Areas Affected by Mild-to-moderate AD, in Patients 2- to 11- Year-old (NCT00510003) | Novartis Pharmaceuticals | 2004-12-01 |
| Efficacy and Safety of Pimecrolimus Cream 1% in Patients ≥ 3 Months of Age With Mild or Moderate Atopic Dermatitis (NCT00150059) | Novartis | 2004-12-01 |
| Blood, Urine, and Tissue Collection for Cutaneous Lymphoma, Eczema, and Atopic Dermatitis Research (NCT00177268) | University of Pittsburgh | 2004-10-01 |
| Combination Therapy for Atopic Dermatitis (NCT00119158) | Children's Hospital of Philadelphia | 2004-10-01 |
| Safety and Efficacy of Pimecrolimus Cream 1% in Mild to Moderate Head and Neck Atopic Dermatitis (AD) Patients (NCT00121316) | Novartis | 2004-10-01 |
| Comparison of Pimecrolimus Cream 1% Twice-Daily to Once-Daily Dosing in the Management of Atopic Dermatitis in Pediatric Subjects (NCT00139581) | Novartis | 2004-09-01 |
| Dietetic Effects of Mare's Milk in Patients With Atopic Dermatitis (NCT00753805) | University of Jena | 2004-08-01 |
| Follow-Up Study of Patients Previously Treated With Pimecrolimus Tablets for Atopic Dermatitis (NCT00098150) | Novartis | 2004-07-01 |
| Study to Evaluate Effect of Pandel Cream 0.1% on HPA Axis in Pediatric and Adult Population (NCT01137032) | Fougera Pharmaceuticals Inc. | 2004-06-01 |
| Extension Study of Pimecrolimus Cream in Pediatric Patients With Atopic Dermatitis (NCT00231998) | Novartis | 2004-05-01 |
| Single Center Study Using Omalizumab in Subjects With Atopic Dermatitis (NCT01678092) | Stanford University | 2004-05-01 |
| Extension Study to Assess Safety and Efficacy of Pimecrolimus in Adult Patients With Atopic Dermatitis (NCT00232011) | Novartis | 2004-05-01 |
| 5-Year Safety Study of Pimecrolimus Cream 1% in Infants 3 - 12 Months of Age With Mild to Moderate Atopic Dermatitis (NCT00120523) | MEDA Pharma GmbH & Co. KG | 2004-04-01 |
| Effects of Pimecrolimus Cream 1% on the Molecular and Cellular Profile of Adult Male Patients With Atopic Dermatitis (NCT00117377) | Novartis | 2004-04-01 |
| Immunologic Basis of Anti-IgE Therapy (Study II: On Patients With Asthma) (NCT00367016) | University of California, Davis | 2004-02-01 |
| Primary Prevention of Atopic Disease by Perinatal Administration of Probiotics (NCT00200954) | The Netherlands Asthma Foundation | 2004-01-01 |
| Safety and Efficacy of Pimecrolimus Cream 1% in Atopic Disease Modification (NCT00124709) | Novartis Pharmaceuticals | 2003-10-01 |
| Broncho-Vaxom (OM 85 BV) in Children Suffering From Atopic Dermatitis (NCT03047954) | Vifor Pharma | 2003-07-01 |
| Psychiatric Problems in Chronic Skin Diseases (NCT00167752) | University of Wisconsin, Madison | 2002-12-01 |
| Photophoresis Versus Ciclosporine in Severe Atopic Dermatitis (NCT02226068) | University of Aarhus | 2002-06-01 |
| Steroid-Sparing Effect With Pimecrolimus in Pediatric Patients With Atopic Dermatitis (NCT00351052) | Novartis | 2001-12-01 |
| Study to Determine the Effect of an Anti-IgE Agent on Inflammatory Cells in the Skin of Atopic Dermatitis Patients (NCT00822783) | Medical University of Vienna | 2001-10-01 |
| Double-Blind, Parallel, Randomised Study to Investigate the Effect of Oral Probiotics in Infants With Atopic Dermatitis (NCT00224432) | Groningen Research Institute for Asthma and COPD | 2001-03-01 |
| Ultraviolet (UVA and UVB) Light Therapy in the Treatment of Inflammatory Skin Conditions (NCT00129415) | University of Michigan | 2000-08-01 |
| Use of Probiotic Bacteria in Prevention of Allergic Disease in Children 1999-2008 (NCT00298337) | University of Helsinki | 1999-10-01 |
| Asthma, a Disease Due to a Lack of Bacterial Infections in Childhood. (NCT00200928) | The Netherlands Asthma Foundation | 1999-01-01 |
| Evaluation and Long-Term Follow-Up of Patients With Allergic and Inflammatory Disorders (NCT00557895) | National Institute of Allergy and Infectious Diseases (NIAID) | 1996-08-26 |
| Abrocitinib Expanded Access Protocol in Adolescents and Adults With Moderate to Severe Atopic Dermatitis (NCT04564755) | Pfizer | |
| Efficacy and Safety Study of MSRD-100 in Subjects With Atopic Dermatitis >=3 Months of Age and Older (NCT02677636) | Merz North America, Inc. | |
| Assessment of the Effects on Barrier Impairment, Clinical Features and Bacterial Colonization of Topical Formulations in Patients With Atopic Eczema; a Phase IIa, Single-center, Randomized, Observer-blind Study (NCT00863005) | Moberg Pharma AB | |
| Efficacy and Safety Study of MSRD-100 in Subjects With Atopic Dermatitis >=3 Months of Age and Older (NCT02677610) | Merz North America, Inc. | |
| Atopic Dermatitis Biomarker Identification Trial in Omalizumab Usage (NCT01179529) | Technical University of Munich | |
| CT 327 in the "Atopy Patch Test" Model (NCT01368315) | Creabilis SA | |
| Expanded Access to Upadacitinib (NCT04159597) | AbbVie | |